tirzepatide weight loss medication FDA approves new version of diabetes drug Mounjaro to be sold for Tirzepatide Weight Loss Injection Dallas

At Pure Medical Spa , we advocate for physician guided alternatives that prioritize patient safety

E.ZangenA

Semaglutide produced less weight loss than tirzepatide head-to-head, about 14% versus 20%. Its body-composition substudy measured a roughly 62:38 fat-to-lean loss split by mass, compared with about 75:25 for tirzepatide in a separate trial. The scan overstates muscle loss because lean mass includes water and organ tissue

Its important to note that while Semaglutide can be effective in managing blood sugar levels and aiding in weight loss, it should be used as part of a comprehensive treatment plan, which may include diet, exercise, and other medications.

Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) Injection site reactions Headache Fatigue Dizziness Important safety considerations include: Risk of hypoglycaemia when used with insulin or sulfonylureas (dose reduction of these agents may be needed) Potential worsening of diabetic retinopathy with semaglutide in patients with pre-existing retinopathy [18] Risk of dehydration and acute kidney injury from persistent vomiting or diarrhoea Pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (observed in rodent studies, though human relevance remains uncertain) [19] [20] Patients should be counselled about persistent severe abdominal pain as a potential warning sign of pancreatitis requiring immediate medical attention

*tip: never use boiling water, instead boil water and let sit 13 min before pouring into bowl to avoid bitterness